(Q21710687)

6 February 2023

6

László Vécsei

László

Vécsei

1 reference

6 February 2023

5

József

Toldi

József Toldi

1 reference

6 February 2023

1

Dénes

Zádori

Dénes Zádori

1 reference

6 February 2023

2

Péter

Klivényi

Péter Klivényi

1 reference

6 February 2023

Levente Szalárdy

3

Levente

Szalárdy

1 reference

22749004

Journal of the Neurological Sciences

6 February 2023

language of work or name

English

0 references

publication date

November 2012

0 references

published in

0 references

volume

322

0 references

issue

1-2

0 references

page(s)

187-191

0 references

cites work

Selective sparing of NADPH-diaphorase neurons in neonatal hypoxia-ischemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Studies on the neuroprotective action of kynurenine mono-oxygenase inhibitors in post-ischemic brain damage.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Neuroprotective effects of kynurenine-3-hydroxylase inhibitors in models of brain ischemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Quinolinic acid is a potent lipid peroxidant in rat brain homogenates

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Role of astrocytes in glutamate homeostasis: implications for excitotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Glutamate receptors, neurotoxicity and neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Neuroprotective effects of probenecid in a transgenic animal model of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Neuroinflammation in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Involvement of kynurenines in Huntington's disease and stroke-induced brain damage

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Glutamate uptake is reduced in prefrontal cortex in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

The role of tryptophan catabolism along the kynurenine pathway in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Metabolism of 6-chlorotryptophan to 4-chloro-3-hydroxyanthranilic acid: a potent inhibitor of 3-hydroxyanthranilic acid oxidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

The effect of peripheral loading with kynurenine and probenecid on extracellular striatal kynurenic acid concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

The kynurenine pathway of tryptophan degradation as a drug target

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Neuroprotective effect of L-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Neuroprotection achieved in the ischaemic rat cortex with L-kynurenine sulphate

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Kynurenine diminishes the ischemia-induced histological and electrophysiological deficits in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Nitric oxide and neuronal death

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Neurotransmitter receptors on microglia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Inducible nitric oxide synthase gene expression in brain following cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Kynurenine is an endothelium-derived relaxing factor produced during inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

The immunology of stroke: from mechanisms to translation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Neurovascular regulation in the normal brain and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

(Peri)vascular production and action of pro-inflammatory cytokines in brain pathology

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Direct evidence that release-stimulating alpha7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

The modulation of mitochondrial nitric-oxide synthase activity in rat brain development.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Expression of polyglutamine-expanded huntingtin induces tyrosine phosphorylation of N-methyl-D-aspartate receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Early and progressive accumulation of reactive microglia in the Huntington disease brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Reactive oxygen radicals in signaling and damage in the ischemic brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Effect of systemic administration of L-kynurenine on corticocerebral blood flow under normal and ischemic conditions of the brain in conscious rabbits

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Distinct neuroinflammatory profile in post-mortem human Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Quinolinic acid effects on amino acid release from the rat cerebral cortex in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Neurovascular protection by ischaemic tolerance: role of nitric oxide.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Cerebral endothelial nitric oxide synthase expression after focal cerebral ischemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Antibodies to brain antigens following stroke

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Syntheses, transformations and pharmaceutical applications of kynurenic acid derivatives

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

Mitochondrial nitric oxide synthase: a masterpiece of metabolic adaptation, cell growth, transformation, and death

1 reference

https://api.crossref.org/works/10.1016%2FJ.JNS.2012.06.004

7 January 2021

10.1016/J.JNS.2012.06.004

Identifiers

DOI

0 references